| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 03/18/2009 | CN101385698A Anti-cancer sustained-released implantation agent |
| 03/18/2009 | CN100469793C Anti-osteopontin antibody and use thereof |
| 03/18/2009 | CN100469792C Regulation of lipid levels via the Zmaxl or HBM gene |
| 03/18/2009 | CN100469789C Variants of allergenic proteins of the Group2 of dermatophagoides |
| 03/18/2009 | CN100469784C Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents |
| 03/18/2009 | CN100469392C Antifungal medicine composition |
| 03/18/2009 | CN100469366C Pharmaceutical formulation comprising a proton pump inhibitor and antacids |
| 03/18/2009 | CN100469361C Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress |
| 03/17/2009 | US7504497 Thrombosis; anticoagulants; renal dialysis; bioavailability |
| 03/17/2009 | US7504482 Recombinant soluble Fc receptors |
| 03/17/2009 | US7504434 3-(acetylamino)-4-{[amino(imino)methyl]amino}-6-carboxy-3,4-dihydro-2H-pyran-2-yl)-dimer; viricide; influenza A or B infection, parainfluenza, mumps or Newcastle disease, myxovirus infections; stability; long time in lungs |
| 03/17/2009 | US7504429 Receptor or non-receptor types; 1H-pyrrole-3-carboxylates; anticarcinogenic, antidiabetic, antiproliferative agents; autoimmune and Crohn's diseases, acromegaly, aging resistance; coadminister tamoxifen, raloxifene, taxol, trastuzumab, tirofiban or a COX-2 inhibitor |
| 03/17/2009 | US7504414 Useful as adjuvants to chemotherapy or radiation therapy to treat cancer; as inhibitors of checkpoint kinase Cds1 (in man also known as Chk2); 2-[4-(3,4-dichloro-phenoxy)-phenyl]-1H-imidazo[4,5-b]pyridine-5-carboxylic acid amide |
| 03/17/2009 | US7504409 Chronic obstructive pulmonary disease; asthma; respiratory system disorders; administering 2-aminonicotinic acid, anthranilic acid, bendroflumethiazide |
| 03/17/2009 | US7504407 2-substituted-4-(imidazolyl or pyrazolyl alkyl)amino-6-phenyl-pyrrolo[2,3-D]pyrimidines; Adenosine receptor inhibitors; asthma, bronchodilators, vision defects, antiischemic and antiinflammatory agents |
| 03/17/2009 | US7504232 Identifying immunomodulators for diagnosis and treatment of inflammatory, granulomatous, fibrosis, multiple sclerosis, bacterial or viral diseases |
| 03/17/2009 | US7504230 for drug screening by assessing the effect on localization of signal transduction proteins, particularly the protein kinase C (PKC) isoenzymes |
| 03/17/2009 | US7504212 Cancer monitoring and therapeutics |
| 03/17/2009 | US7504102 Therapeutic mixture comprising immunoglobulin specific to vitronectin receptor for use in diagnosis, prevention and treatment of restenosis |
| 03/17/2009 | US7504096 Methods for in vitro fertilization |
| 03/17/2009 | CA2502731C Sustained release composition for oral administration of drugs |
| 03/17/2009 | CA2355712C Antiviral nucleoside analogues |
| 03/17/2009 | CA2338638C Use of l-carnitine and its alkanoyl derivatives in the preparation of medicaments with anticancer activity |
| 03/17/2009 | CA2330025C Methods and compositions useful for modulation of angiogenesis using tyrosine kinase src |
| 03/12/2009 | WO2009032972A1 Compositions and methods for treating immunological and inflammatory diseases and disorders |
| 03/12/2009 | WO2009032172A2 Platinum compositions as treatment for oct-related cancers |
| 03/12/2009 | WO2009030998A1 Pyrimidine compounds as toll-like receptor (tlr) agonists |
| 03/12/2009 | WO2009030996A1 Triazole compounds as toll-like receptor (tlr) agonists |
| 03/12/2009 | WO2009007680A3 Combinations comprising a mast cell inhibitor and a statin for use in the treatment of inflammatory disorders |
| 03/12/2009 | WO2009007679A3 Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a thromboxane a2 antagonist |
| 03/12/2009 | WO2009007675A3 Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a p2 gamma 12 antagonist |
| 03/12/2009 | WO2009004082A3 Anticonvulsive pharmaceutical compositions |
| 03/12/2009 | WO2008135855A3 Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and a nonionizable polymer |
| 03/12/2009 | WO2008124088A3 Compositions and methods for the treatment of heart failure |
| 03/12/2009 | WO2008094737A3 Purine compounds and compositions as kinase inhibitors for the treatment of plasmodium related diseases |
| 03/12/2009 | WO2008059052A9 Improved methods of using phosphoantigen for the treatment of cancer |
| 03/12/2009 | WO2008021389A8 Using pi3k and mek modulators in treatments of cancer |
| 03/12/2009 | US20090069414 Epicatechin and vasodilation |
| 03/12/2009 | US20090069394 Cancer treatment with epothilones |
| 03/12/2009 | US20090069361 Methods of treatment using (+)- isopropyl 2-methoxyethyl 4-(2-chloro-3-cyano-phenyl)-1, 4-dihydro-2, 6-dimethyl-pyridine-3, 5-dicarboxylate |
| 03/12/2009 | US20090069348 Use of Inhibitors of the Renin-Angiotensin System |
| 03/12/2009 | US20090069290 Administering formulation selected from calcium-channel blocker; a combination of a calcium-channel blocker and glutamate inhibitor; a combination of a calcium-channel blocker and hypertensive agent or mixtures |
| 03/12/2009 | US20090069279 Invert emulsions containing dhea |
| 03/12/2009 | US20090069225 Somatostatin analogues |
| 03/12/2009 | US20090068289 Formulation for menopausal women |
| 03/12/2009 | US20090068273 Prophylaxis of respiratory disorders such as asthma; composition with PDE4 inhibitor, corticosteroid hibitor or anticholinergic agent; 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol or salt |
| 03/12/2009 | US20090068210 Immunotherapy for hematological malignancies |
| 03/12/2009 | US20090068209 Cytotoxic Lymphocyte |
| 03/12/2009 | US20090068205 Antiproliferative agents; anticancer agents; composition comprising antagonist of a human ErbB4 receptor, in admixture with a pharmaceutically acceptable carrier; antagonist selected from group consisting of an antibody produced by a hybridoma selected from the group containing HER4.10H1.1A1 |
| 03/12/2009 | US20090068193 Treatment And Prophylaxis With 4-1BB-Binding Agents |
| 03/12/2009 | US20090068185 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 03/12/2009 | US20090068155 Methods, pharmaceutical compositions and articles of manufacture for administering therapeutic cells to the animal central nervous system |
| 03/12/2009 | US20090068152 Gene transfer for regulating smooth muscle tone |
| 03/12/2009 | US20090068151 Methods and reagents for the enhancement of virus transduction in the bladder epithelium |
| 03/12/2009 | US20090068142 Compositions and methods for treating coronavirus infection and sars |
| 03/12/2009 | US20090068094 Inhibitors of endo-exonuclease activity for treating cancer |
| 03/12/2009 | CA2698713A1 Compositions and methods for treating immunological and inflammatory diseases and disorders |
| 03/11/2009 | EP2034030A2 Novel compositions and methods for cancer |
| 03/11/2009 | EP2034018A1 Genetically modified animal and use thereof |
| 03/11/2009 | EP2033952A1 Nitrogen-containing Heteroaryl compounds having HIV Integrase Inhibitory Activity |
| 03/11/2009 | EP2033951A2 2-Piperazine-pyridines useful for treating pain |
| 03/11/2009 | EP2033659A2 Inhibitors of complement activation |
| 03/11/2009 | EP2033652A1 Treatment of inflammatory bowel disease |
| 03/11/2009 | EP2033648A2 Sustained release drug delivery system containing codrugs |
| 03/11/2009 | EP2033646A1 Prophylactic and/or therapeutic agent for rheumatoid arthritis |
| 03/11/2009 | EP2033635A1 Short-chain fatty acid derivatives for treating pruritus |
| 03/11/2009 | EP2033633A2 Partial fatty acid oxidation inhibitors in the treatment of congestive heart failure |
| 03/11/2009 | EP2032748A1 Serpine1 polymorphisms are predictive of response to activated protein c administration and risk of death |
| 03/11/2009 | EP2032596A1 Neuroprotective compounds and uses thereof |
| 03/11/2009 | EP2032148A2 Composition containing lactobacillus sp. and a cannabinoid receptor and/or a opioid receptor agonist |
| 03/11/2009 | EP2032132A2 Compositions comprising tegaserod alone or in combination with a proton pump inhibitor for treating or preventing gastric injury |
| 03/11/2009 | EP2031964A2 Treating obesity with muscarinic receptor m1 antagonists |
| 03/11/2009 | EP1763368B1 Combinations comprising antimuscarinic agents and beta-adrenergic agonists |
| 03/11/2009 | EP1759199A4 Insulin-independent, bone morphogenetic protein (bmp)-mediated uptake of blood glucose by peripheral cells and tissues |
| 03/11/2009 | EP1737488B1 Treatment of fungal infections |
| 03/11/2009 | EP1485364B1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 03/11/2009 | EP1435899B1 A composition for promoting hair growth |
| 03/11/2009 | EP1429845B1 Treatment or prophylaxis of insulin-producing cell graft rejection |
| 03/11/2009 | EP1411899B1 Taste masking composition |
| 03/11/2009 | EP1349840B1 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto |
| 03/11/2009 | EP1318801B1 Topical analgesic compositions containing aliphatic polyamines and methods of using same |
| 03/11/2009 | EP1299081B9 Use of oligosaccharides to stimulate beta-endorphin production |
| 03/11/2009 | EP1185255B1 RETINOPROTECTIVE OPHTHALMOLOGIC MEDICINES comprising ramipril or ramiprilat |
| 03/11/2009 | CN101384301A Proteasom or ups inhibitor for treating infections with influenza viruses |
| 03/11/2009 | CN101384277A Novel anticancer cathepsin preparation and anticancer agent for combination therapy against cancer using the same |
| 03/11/2009 | CN101384254A Use of a compound that enhances gabaa-ergic neurotransmission for the treatment of inflammatory diseases |
| 03/11/2009 | CN101381366A Benzimidazole derivative and its use as a ii receptor antagonist |
| 03/11/2009 | CN101380476A Albumin-binding derivatives of therapeutic peptides |
| 03/11/2009 | CN101380464A Method for treating a movement disorder |
| 03/11/2009 | CN101380463A Composition and its therapeutic use |
| 03/11/2009 | CN101380320A The use of cholinesterase inhibitors in the treatment of xerostomia |
| 03/11/2009 | CN101380319A Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
| 03/11/2009 | CN101380317A Pharmaceutical composition for easing pruritus |
| 03/11/2009 | CN101380309A Metered dose inhalation aerosol and preparation method thereof |
| 03/11/2009 | CN101380308A Anticancer sustained-release preparation loaded with anti-cancer medicine and synergist thereof |
| 03/11/2009 | CN101380307A Anticancer sustained-release formulation loaded with anti-cancer medicine and synergist thereof |
| 03/11/2009 | CN101380306A Compound platinum medicine sustained-release agent |
| 03/11/2009 | CN101380299A Sustained-release injection containing methotrexate and synergist thereof |
| 03/11/2009 | CN101380298A Methotrexate sustained-release injection |
| 03/11/2009 | CN101380297A Compound platinum medicine sustained-release agent |